price close januari
ep minu
stock base comp cash
debt total capit
even held call felt like dj vu period
year ago compani provid better-than-expect procedur guidanc
upcom year project lower gross margin much higher op ex street
expect thing last year believ typic conserv stanc
manag though commentari bit concern longer expect
sale cycl new system competit markedli higher sg spend
last year stock trade adjust price-to-earnings today adjust stock base
comp cash trade price-to-earnings valuat remain neutral share even
potenti pocket upsid guidanc given favor procedur guidanc
updat pt base adjust ep
compani pre-announce sale earli januari result even
somewhat known howev dig deeper result key driver
solid compani yet specif saw nice uptick demand notabl
europ placement along increas oper
leas highlight multi-ti price strategi pay drive upgrad
provid better expect procedur guidanc earli januari provid
gm op ex guidanc call disappoint investor thing
happen year earli januari provid procedur growth
tonight provid gross margin guidanc
op ex growth consensu sale growth lower gross
margin op ex grow faster sale impli compress ebit margin
term ep growth compani benefit lower tax rate enough
off-set increas op ex consensu earn estim like come
point call biggest piec new inform call
higher-than-expect oper expens outlook much spend go
clinic studi new rep addit intern procedur side
gener surgeri continu grow see slow despit
continu believ lack meaning benefit compar laparoscop
techniqu final manag indic hire ceo/cfo
manag member jv partnership fosun china overse new
flex platform compani state track intern timelin
follow call manag note start hire sale rep
platform yet mean launch like next sever quarter
payer push back price procedur volum slowdown
make robot system use varieti surgic procedur
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
million except per share data
instrument accessori
product
total revenu
sell gener administr
research develop
incom oper
interest incom expens net
incom tax
non-recur item tax
sg sale
 sale
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
